Aziyo Biologics Inc reports results for the quarter ended in September - Earnings Summary

Elutia

14/11/2022 22:39

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 73 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 66 cents per share.
    * Revenue rose 7.9% to $12.39 million from a year ago;
analysts
expected $12.38 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 73 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had risen by 11.2% this
quarter and
gained 27.1% so far this year.
    * The company reported a quarterly loss of $9.91 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $10.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.66          -0.73          Missed
 Jun. 30 2022      -0.56          -0.69          Missed
 Mar. 31 2022      -0.62          -0.60          Beat
 Dec. 31 2021      -0.68          -0.82          Missed